Keywords: CB1، گیرنده کانابینوئید نوع 1; Drug repurposing; Tuberculosis; Rimonabant; BM212; Sila analogue; MmpL3 inhibitorMIC, Minimum Inhibitory Concentration; ADME, absorption, distribution, metabolism, excretion; CB1, Cannabinoid receptor Type 1; Mtb, Mycobacterium tuberculosis; CNS, Central
مقالات ISI CB1، گیرنده کانابینوئید نوع 1 (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: CB1، گیرنده کانابینوئید نوع 1; CB1, cannabinoid receptor type 1; CB2, cannabinoid receptor type 2; CBD, cannabidiol; EPM, elevated plus maze; GABA, gamma aminobutyric acid; GPR55, G protein-coupled receptor 55; HT, open field habituation test; IOP, intraocular pressure; i.p., intraperi
Keywords: CB1، گیرنده کانابینوئید نوع 1; HPA, hypothalamo–pituitary–adrenal; eCB, endocannabinoid; CB1, cannabinoid receptor type 1; THC, Δ9-tetrahydrocannabinol; AEA, N-arachidonylethanolamine; 2-AG, 2-arachidonoylglycerol; PEA, palmitoylethanolamide; OEA, oleoylethanolamide; ER, endoplasmic re
Keywords: CB1، گیرنده کانابینوئید نوع 1; 6-OHDA, 6-hydroxydopamine; 2-AG, 2-arachidonoylglycerol; BDNF, brain derived neurotrophic factor; CB1, cannabinoid receptor type 1; Cg, cingulate cortex; CNS, central nervous system; CO2, carbon dioxide; Cpudl, caudate putamen dorsolateral; Cpum, caudate
Keywords: CB1، گیرنده کانابینوئید نوع 1; Endocannabinoid; Basolateral amygdala; Anxiety; FAAH; Emotional arousal; CorticosteroneAEA, Anandamide; 2-AG, 2-arachidonoylglycerol; BLA, Basolateral nucleus of the amygdala; CB1, Cannabinoid receptor type 1; CB2, Cannabinoid receptor type 2; CRH, Cortic
Keywords: CB1، گیرنده کانابینوئید نوع 1; CB1, cannabinoid receptor type 1; COX, cyclooxygenase; I-RTX, iodoresiniferatoxin; NSAIDs, non-steroidal antiinflammatory dugs; PAG, periaqueductal gray; RVM, rostral ventromedial medulla; TRPV1, transient receptor potential vanilloid 1Dipyrone; Arachidon
Keywords: CB1، گیرنده کانابینوئید نوع 1; 2-AG, 2-arachidonoylglycerol; BAPTA, 1,2-bis(2-aminophenoxy)ethane-N,N,N′,N′-tetraacetic acid; cAMP, cyclic adenosine monophosphate; CB1, cannabinoid receptor type 1; CNS, central nervous system; DA, dopamine; DAG, diacylglycerol; DGLα, diacylglycerol lip
Keywords: CB1، گیرنده کانابینوئید نوع 1; ACSF, artificial CSF; APs, action potentials; AP5, (2R)-amino-5-phosphonovaleric acid; CB1, cannabinoid receptor type 1; CPu, caudate-putamen; DV, dorso-ventral; ECS, endocannabinoid system; EGTA, ethylene glycol tetraacetic acid; GHR, ghrelin; HEPES, 2-[
Allopregnanolone in the brain: Protecting pregnancy and birth outcomes
Keywords: CB1، گیرنده کانابینوئید نوع 1; 3αHSD, 3α-hydroxysteroid dehydrogenase; ACTH, adrenocorticotropic hormone; AgRP, agouti-related peptide; AVP, arginine vasopressin; CCK, cholecystokinin; CB1, cannabinoid receptor type 1; CeA, central nucleus of the amygdala; cGMP, cyclic guanosine monoph
Functional interactions within striatal microcircuit in animal models of Huntington's disease
Keywords: CB1، گیرنده کانابینوئید نوع 1; striatum; neurodegenerative disorders; interneurons; HD animal models; synaptic changes; corticostriatal pathwayA2a, adenosine receptor; ACh, acetylcholine; BDNF, brain-derived neurotrophic factor; cAMP, cyclic AMP; CB1, cannabinoid receptor type 1; ChAT,
Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress
Keywords: CB1، گیرنده کانابینوئید نوع 1; 5-HT1A receptor, 5-hydroxytryptamine (serotonin) receptor subtype 1A; A2A, adenosine A2A receptor (ADORA2A); Abn-CBD, abnormal-cannabidiol; Aβ, β-amyloid peptide; BHT, butylated hydroxytoluene; CB1, cannabinoid receptor type 1; CB2, cannabinoid receptor t
The gut microbiome as therapeutic target
Keywords: CB1، گیرنده کانابینوئید نوع 1; Gut microbiota; LPS; Obesity/type 2 diabetes; Gut permeability; Inflammation; Endocannabinoid systemACC, Acetyl-CoA Carboxylase; AMPK, AMP-Activated Protein Kinase; CB1, Cannabinoid Receptor type 1; ChREBP, Carbohydrate Responsive Element Binding Protein;
Determination of endocannabinoids in nematodes and human brain tissue by liquid chromatography electrospray ionization tandem mass spectrometry
Keywords: CB1، گیرنده کانابینوئید نوع 1; 2-AG, 2-arachidonoyl glycerol; 2-AG-d8, deuterated 2-arachidonoyl glycerol; AEA, arachidonoylethanolamide (anandamide); AEA-d8, deuterated arachidonoylethanolamide; C. elegans N2, Caenorhabditis elegans wild type; CB1, cannabinoid receptor type 1; CB2, ca
Interactions between specific parameters of cannabis use and verbal memory
Keywords: CB1، گیرنده کانابینوئید نوع 1; ∆9-THC, delta-9-tetrahydrocannabinol; 2-AG, 2-arachidonyl glycerol; CB1, cannabinoid receptor type 1; EAU, early age of first use; HDO, high average dose per occasion; HFU, high frequency of use; HLD, high lifetime dose; LAU, late age of first use; LDO, l
Synthesis and pharmacological evaluation of coumarin derivatives as cannabinoid receptor antagonists and inverse agonists
Keywords: CB1، گیرنده کانابینوئید نوع 1; AIDS, acquired immune deficiency syndrome; BSA, bovine serum albumin; CB1, cannabinoid receptor type 1; CB2, cannabinoid receptor type 2; DABCO, 1,4-diazobicyclo[2.2.2]octane; DIC, diisopropylcarbodiimide; DMAP, 4-(dimethylamino)pyridine; DTT, dithiothrei
Hippocampal interneurons co-express transcripts encoding the α7 nicotinic receptor subunit and the cannabinoid receptor 1
Keywords: CB1، گیرنده کانابینوئید نوع 1; CB1; 5-HT3 receptors; 5-HT; CCK; Alzheimer’s disease; schizophreniaBSA, bovine serum albumin; CB1, cannabinoid receptor type 1; CCK, cholecystokinin; DEPC, diethyl pyrocarbonate; DG, dentate gyrus; GAD, glutamate decarboxylase; nACh, nicotinic acetylcholi
Dysregulation of peripheral endocannabinoid levels in hyperglycemia and obesity: Effect of high fat diets
Keywords: CB1، گیرنده کانابینوئید نوع 1; AEA, arachidonoylethanolamide (anandamide); 2-AG, 2-arachidonoylglycerol; CB1, cannabinoid receptor type 1; CB2, cannabinoid receptor type 2; DAGL, diacylglycerol lipase; EC, endocannabinoid; FAAH, fatty acid amide hydrolase; HFD, high fat diet; STD, stan
Influence of dietary fatty acids on endocannabinoid and N-acylethanolamine levels in rat brain, liver and small intestine
Keywords: CB1، گیرنده کانابینوئید نوع 1; AA, arachidonic acid; 2-AG, 2-arachidonoylglycerol; AEA, anandamide, arachidonoylethanolamide; CB1, cannabinoid receptor type 1; DHA, docosahexaenoic acid; DHEA, docosahexaenoylethanolamide; EPA, eicosapentaenoic acid; EPEA, eicosapentaenoylethanolamide;
Selective 5-HT6 receptor ligands: Progress in the development of a novel pharmacological approach to the treatment of obesity and related metabolic disorders
Keywords: CB1، گیرنده کانابینوئید نوع 1; 5-HT6 ligands; Metabolic disorders; Obesity; Rodent models; TreatmentBMI, body mass index; CB1, cannabinoid receptor type 1; CoMFA, comparative molecular field analysis; CoMSIA, comparative molecular similarity indices analysis; DIO, dietary-induced obese
Development of the first potent and specific inhibitors of endocannabinoid biosynthesis
Keywords: CB1، گیرنده کانابینوئید نوع 1; AA-5-HT, arachidonoyl-5-hydroxytryptamine; 2-AG, 2-Arachidonoyl-glycerol; AMT, anandamide membrane transporter; CB1, cannabinoid receptor type 1; CB2, cannabinoid receptor type 2; [3H]CP-55,940, [3H]-(−)-cis-3-[2-hydroxy-4-(1,1-dimethylheptyl)-phenyl]-tra
Rimonabant: A Cannabinoid Receptor Type 1 Blocker for Management of Multiple Cardiometabolic Risk Factors
Keywords: CB1، گیرنده کانابینوئید نوع 1; BMI, body mass index; CB1, cannabinoid receptor type 1; HDL, high-density lipoprotein; LDL, low-density lipoprotein; RIO, Rimonabant in Obesity; STRATUS, Studies with Rimonabant and Tobacco Use; THC, tetrahydrocannabinol
Cannabinoid receptor ligands mediate growth inhibition and cell death in mantle cell lymphoma
Keywords: CB1، گیرنده کانابینوئید نوع 1; MCL, mantle cell lymphoma; CB1, cannabinoid receptor type 1; CB2, cannabinoid receptor type 2; Win-55,212-2, (R)-(+)-Win-55,212-2 (2,3 dihydro)-5-methyl-3 [(morpholinyl)-methyl]pyrollo (1,2,3 de)-1,4-benzoxazinyl]-[1-naphthaleny]methanone; anandamide, ara